Annual EPS
-$1.52
+$6.99+82.14%
March 31, 2024
Summary
- As of February 26, 2025, VTGN annual earnings per share is -$1.52, with the most recent change of +$6.99 (+82.14%) on March 31, 2024.
- During the last 3 years, VTGN annual EPS has risen by +$13.18 (+89.66%).
Performance
VTGN EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.46
-$0.04-9.52%
December 31, 2024
Summary
- As of February 26, 2025, VTGN quarterly earnings per share is -$0.46, with the most recent change of -$0.04 (-9.52%) on December 31, 2024.
- Over the past year, VTGN quarterly EPS has dropped by -$0.11 (-31.43%).
Performance
VTGN Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.58
-$0.24-17.88%
December 31, 2024
Summary
- As of February 26, 2025, VTGN TTM earnings per share is -$1.58, with the most recent change of -$0.24 (-17.88%) on December 31, 2024.
- Over the past year, VTGN TTM EPS has stayed the same.
Performance
VTGN TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
VTGN EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +82.1% | -31.4% | 0.0% |
| 3 y3 years | +89.7% | -31.4% | 0.0% |
| 5 y5 years | +94.4% | -31.4% | 0.0% |
VTGN EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.7% | -109.1% | +84.0% | -17.9% | +83.7% |
| 5 y | 5-year | at high | +94.4% | -109.1% | +90.6% | -17.9% | +90.9% |
| alltime | all time | <-9999.0% | +99.8% | <-9999.0% | +99.9% | <-9999.0% | +99.8% |
VistaGen Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$0.46(+9.5%) | -$1.58(+17.9%) |
| Sep 2024 | - | -$0.42(+20.0%) | -$1.34(-15.2%) |
| Jun 2024 | - | -$0.35(-0.7%) | -$1.58(-27.2%) |
| Mar 2024 | -$1.52(-82.1%) | -$0.35(+60.1%) | -$2.17(-38.1%) |
| Dec 2023 | - | -$0.22(-66.7%) | -$3.51(-25.5%) |
| Sep 2023 | - | -$0.66(-29.8%) | -$4.71(-28.5%) |
| Jun 2023 | - | -$0.94(-44.4%) | -$6.59(-22.7%) |
| Mar 2023 | -$8.51(+15.3%) | -$1.69(+19.0%) | -$8.52(-9.5%) |
| Dec 2022 | - | -$1.42(-44.1%) | -$9.41(-0.8%) |
| Sep 2022 | - | -$2.54(-11.5%) | -$9.49(+4.9%) |
| Jun 2022 | - | -$2.87(+11.3%) | -$9.05(+22.6%) |
| Mar 2022 | -$7.38(-49.8%) | -$2.58(+72.0%) | -$7.38(-24.0%) |
| Dec 2021 | - | -$1.50(-28.6%) | -$9.71(-5.8%) |
| Sep 2021 | - | -$2.10(+75.0%) | -$10.31(+6.2%) |
| Jun 2021 | - | -$1.20(-75.6%) | -$9.71(-8.5%) |
| Mar 2021 | -$14.70(-2.0%) | -$4.91(+133.8%) | -$10.61(+36.0%) |
| Dec 2020 | - | -$2.10(+40.0%) | -$7.80(-23.5%) |
| Sep 2020 | - | -$1.50(-28.6%) | -$10.20(-19.0%) |
| Jun 2020 | - | -$2.10(0.0%) | -$12.60(-16.0%) |
| Mar 2020 | -$15.00(-44.4%) | -$2.10(-53.3%) | -$15.00(-13.8%) |
| Dec 2019 | - | -$4.50(+15.4%) | -$17.40(-13.4%) |
| Sep 2019 | - | -$3.90(-13.3%) | -$20.10(-20.2%) |
| Jun 2019 | - | -$4.50(0.0%) | -$25.20(-5.6%) |
| Mar 2019 | -$27.00(-19.6%) | -$4.50(-37.5%) | -$26.70(-4.2%) |
| Dec 2018 | - | -$7.20(-20.0%) | -$27.88(-1.1%) |
| Sep 2018 | - | -$9.00(+50.0%) | -$28.18(-19.7%) |
| Jun 2018 | - | -$6.00(+5.6%) | -$35.08(-6.4%) |
| Mar 2018 | -$33.60(-27.3%) | -$5.68(-24.3%) | -$37.48(-8.8%) |
| Dec 2017 | - | -$7.50(-52.8%) | -$41.10(-6.2%) |
| Sep 2017 | - | -$15.90(+89.3%) | -$43.80(+8.1%) |
| Jun 2017 | - | -$8.40(-9.7%) | -$40.50(-14.6%) |
| Mar 2017 | -$46.20(-94.7%) | -$9.30(-8.8%) | -$47.40(-67.8%) |
| Dec 2016 | - | -$10.20(-19.0%) | -$147.00(-24.7%) |
| Sep 2016 | - | -$12.60(-17.6%) | -$195.30(-42.6%) |
| Jun 2016 | - | -$15.30(-86.0%) | -$340.50(-62.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | -$872.40(+174.1%) | -$108.90(+86.2%) | -$902.10(-2.8%) |
| Dec 2015 | - | -$58.50(-62.9%) | -$928.20(+2.9%) |
| Sep 2015 | - | -$157.80(-72.6%) | -$902.10(+12.6%) |
| Jun 2015 | - | -$576.90(+327.3%) | -$801.30(+138.9%) |
| Mar 2015 | -$318.30(+178.5%) | -$135.00(+316.7%) | -$335.40(+34.4%) |
| Dec 2014 | - | -$32.40(-43.2%) | -$249.60(+8.3%) |
| Sep 2014 | - | -$57.00(-48.6%) | -$230.40(+7.4%) |
| Jun 2014 | - | -$111.00(+125.6%) | -$214.50(+85.7%) |
| Mar 2014 | -$114.30(-85.0%) | -$49.20(+272.7%) | -$115.50(-28.8%) |
| Dec 2013 | - | -$13.20(-67.9%) | -$162.30(-75.4%) |
| Sep 2013 | - | -$41.10(+242.5%) | -$659.10(-4.5%) |
| Jun 2013 | - | -$12.00(-87.5%) | -$690.00(-7.3%) |
| Mar 2013 | -$762.00(+53.0%) | -$96.00(-81.2%) | -$744.00(-1.7%) |
| Dec 2012 | - | -$510.00(+608.3%) | -$756.97(+82.2%) |
| Sep 2012 | - | -$72.00(+9.1%) | -$415.35(-4.2%) |
| Jun 2012 | - | -$66.00(-39.4%) | -$433.35(-13.2%) |
| Mar 2012 | -$498.00(<-9900.0%) | -$108.97(-35.3%) | -$499.35(+27.9%) |
| Dec 2011 | - | -$168.38(+87.1%) | -$390.38(+75.8%) |
| Sep 2011 | - | -$90.00(-31.8%) | -$222.00(+68.2%) |
| Jun 2011 | - | -$132.00(<-9900.0%) | -$132.00(<-9900.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2007 | - | $0.00 | $0.00 |
FAQ
- What is VistaGen Therapeutics annual earnings per share?
- What is the all time high annual EPS for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual EPS year-on-year change?
- What is VistaGen Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly EPS year-on-year change?
- What is VistaGen Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for VistaGen Therapeutics?
- What is VistaGen Therapeutics TTM EPS year-on-year change?
What is VistaGen Therapeutics annual earnings per share?
The current annual EPS of VTGN is -$1.52
What is the all time high annual EPS for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual earnings per share is $0.00
What is VistaGen Therapeutics annual EPS year-on-year change?
Over the past year, VTGN annual earnings per share has changed by +$6.99 (+82.14%)
What is VistaGen Therapeutics quarterly earnings per share?
The current quarterly EPS of VTGN is -$0.46
What is the all time high quarterly EPS for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly earnings per share is $0.00
What is VistaGen Therapeutics quarterly EPS year-on-year change?
Over the past year, VTGN quarterly earnings per share has changed by -$0.11 (-31.43%)
What is VistaGen Therapeutics TTM earnings per share?
The current TTM EPS of VTGN is -$1.58
What is the all time high TTM EPS for VistaGen Therapeutics?
VistaGen Therapeutics all-time high TTM earnings per share is $0.00
What is VistaGen Therapeutics TTM EPS year-on-year change?
Over the past year, VTGN TTM earnings per share has changed by $0.00 (0.00%)